Inflammation-related 5-hydroxymethylation signatures as markers for clinical presentations of coronary artery disease.

Abstract

Authors

• Jing Xu
  First Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China.
• Hangyu Chen
  Department of Pharmacy, Peking University Third Hospital, 49 Huayuan North Rd, Haidian District, Beijing, 100191, China.
• Jingang Yang
  Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China.
• Yanmin Yang
  Hebei Key Laboratory of Optic-electronic Information and Materials, College of Physics Science and Technology, Hebei University, Baoding 071002, China. Electronic address: yangym@hbu.edu.cn.
• Yuan Wu
  State Key Laboratory of Precision Spectroscopy, Quantum Institute for Light and Atoms, Department of Physics and Electronic Science, East China Normal University, Shanghai 200062, China.
• Jun Zhang
  First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
• Jiansong Yuan
  State Key Laboratory of Cardiovascular Diseases, Department of Cardiology, Fuwai Hospital & National Center for Cardiovascular Diseases, 167 Beilishi Road, Xicheng District, Beijing, 100037, China.
• Tianjie Wang
  State Key Laboratory of Cardiovascular Diseases, Department of Cardiology, Fuwai Hospital & National Center for Cardiovascular Diseases, 167 Beilishi Road, Xicheng District, Beijing, 100037, China.
• Tao Tian
  State Key Laboratory of Cardiovascular Diseases, Department of Cardiology, Fuwai Hospital & National Center for Cardiovascular Diseases, 167 Beilishi Road, Xicheng District, Beijing, 100037, China.
• Jia Li
  Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan Tsuihang New District, Guangdong, 528400, PR China; School of Pharmacy, Zunyi Medical University, Zunyi, 563000, PR China; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China.
• Xueyan Zhao
  Institute of Chemical Materials, China Academy of Engineering Physics, Mianyang621900, China.
• Xiaojin Gao
  State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
• Jie Lu
  Department of Endocrinology and Metabolism, the Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.
• Lin Li
  Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
• Lei Zhang
  Division of Gastroenterology, Union Hospital, Tongji Medical College Medical College, Huazhong University of Science and Technology, Wuhan, China.
• Xuehui Li
  College of Pharmacy, Xinjiang Medical University, Urumqi, 830011, China.
• Long Chen
  Department of Critical Care Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
• Chuan He
  School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300350, PR China.
• Chaoran Dong
  Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Xian Nong Tan Street 1, Xicheng District, Beijing, 100050, China. dongcr@imm.ac.cn.
• Jian Lin
  Synthetic and Functional Biomolecules Center, Peking University, Beijing, 100871, China.
• Weixian Yang
  State Key Laboratory of Cardiovascular Diseases, Department of Cardiology, Fuwai Hospital & National Center for Cardiovascular Diseases, 167 Beilishi Road, Xicheng District, Beijing, 100037, China. wxyang2009@sina.com.
• Yuejin Yang
  Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Beijing, China.

Keywords

External Resources